Individuals diagnosed with intrahepatic cholangiocarcinoma (iCCA), a type of liver cancer, face a five-year survival rate of less than 10 percent. But a Wilmot Cancer Institute team that also investigates pancreatic cancer, ...
Sep 13, 2021
0
7
A new study has shown that treating type 1 diabetes-prone mice with the small protein MOTS-c prevented the immune system from destroying insulin-producing pancreatic cells, effectively preventing the onset of the autoimmune ...
Aug 16, 2021
0
756
One of the reasons pancreatic cancer remains the most deadly of the major cancers is that it craftily rewires normal cell survival mechanisms to keep itself supplied with nutrients to fuel its expansion.A new study led by ...
Aug 11, 2021
0
525
Pancreatic cancer, which affects about 60,000 Americans every year, is one of the deadliest forms of cancer. After diagnosis, fewer than 10 percent of patients survive for five years.
Aug 5, 2021
0
207
The ruthenium-based anticancer agent BOLD-100 just received an Orphan Drug Designation in the treatment of gastric (stomach) cancer from the U.S. Food and Drug Administration. The small molecule therapeutic originally developed ...
Jul 21, 2021
0
1
A new study from Queen Mary University of London has demonstrated that immune cells can be stimulated to assemble into special structures within pancreatic cancer such that, at least in a pre-clinical model, researchers can ...
Jul 9, 2021
0
7
Researchers from Queen Mary University of London have identified a protein that could be used to aid in the diagnosis of pancreatic cancer.
Jun 29, 2021
0
39
Cancer cells can become resistant to treatments through adaptation, making them notoriously tricky to defeat and highly lethal. Cold Spring Harbor Laboratory (CSHL) Cancer Center Director David Tuveson and his team investigated ...
Jun 22, 2021
0
19
Pancreatic cancer is an aggressive disease in which malignant cells form in the tissues of the pancreas, a long and flat gland located behind the stomach that helps with digestion and blood sugar regulation. Because pancreatic ...
Jun 15, 2021
0
24
A large international team of researchers has conducted genetic engineering on T cells as a way to combat pancreatic cancer. In their paper published in the journal Nature Biomedical Engineering, the group describes engineering ...
